The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus; S Baos; H Cappel-Porter; A Carson-Stevens; MC Clout; L Culliford; SR Emmett; J Garstang; L Gbadamoshi; B Hallis; RA Harris; D Hutton; CT Group

doi:10.2139/ssrn.3931758

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, MC Clout, L Culliford, SR Emmett, J Garstang, L Gbadamoshi, B Hallis, RA Harris, D Hutton, CT Group

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.2139/ssrn.3931758 https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291
Publication status	Published - 30 Sept 2021

Research Groups and Themes

BTC (Bristol Trials Centre)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Handle.net

Persistent link

Cite this

Lazarus, R., Baos, S., Cappel-Porter, H., Carson-Stevens, A., Clout, MC., Culliford, L., Emmett, SR., Garstang, J., Gbadamoshi, L., Hallis, B., Harris, RA., Hutton, D., & Group, CT. (2021). The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). The Lancet. https://doi.org/10.2139/ssrn.3931758, https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291

@article{077baeb5f1c34e5893365fb4a1f17c24,

title = "The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)",

author = "R Lazarus and S Baos and H Cappel-Porter and A Carson-Stevens and MC Clout and L Culliford and SR Emmett and J Garstang and L Gbadamoshi and B Hallis and RA Harris and D Hutton and CT Group",

year = "2021",

month = sep,

day = "30",

doi = "10.2139/ssrn.3931758",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

Lazarus, R , Baos, S, Cappel-Porter, H, Carson-Stevens, A, Clout, MC , Culliford, L, Emmett, SR, Garstang, J, Gbadamoshi, L, Hallis, B, Harris, RA, Hutton, D & Group, CT 2021, 'The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)', The Lancet. https://doi.org/10.2139/ssrn.3931758, https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). / Lazarus, R ; Baos, S; Cappel-Porter, H et al.
In: The Lancet, 30.09.2021.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

AU - Lazarus, R

AU - Baos, S

AU - Cappel-Porter, H

AU - Carson-Stevens, A

AU - Clout, MC

AU - Culliford, L

AU - Emmett, SR

AU - Garstang, J

AU - Gbadamoshi, L

AU - Hallis, B

AU - Harris, RA

AU - Hutton, D

AU - Group, CT

PY - 2021/9/30

Y1 - 2021/9/30

UR - http://europepmc.org/abstract/PPR/PPR418587

UR - https://www.sciencedirect.com/science/article/pii/S0140673621023291

U2 - 10.2139/ssrn.3931758

DO - 10.2139/ssrn.3931758

M3 - Article (Academic Journal)

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -

Lazarus R , Baos S, Cappel-Porter H, Carson-Stevens A, Clout MC , Culliford L et al. The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). The Lancet. 2021 Sept 30. doi: 10.2139/ssrn.3931758, https://www.sciencedirect.com/science/article/pii/S0140673621023291

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

Research Groups and Themes

UN SDGs

Access to Document

Handle.net

Other files and links

Cite this